A prospective blood sample collection study to evaluate a panel of protein-based biomarkers.


Certain components in the blood, called biomarkers, are only present in an individual when they have a certain type of illness, such as cancer. Many cancers have a high rate of severe outcomes and require more invasive treatments due to our current inability to detect them early on in their disease progression. Typically, when a cancer is discovered early on, it is relatively more manageable and treatable. The purpose of this trial is to identify biomarkers that may be present in an individual and may suggest an early stage of many types of cancers including pancreatic, liver and ovarian cancers. By detecting these cancers when they are first developing, we may be able to decrease the mortality rate associated with them and decrease the requirements for more invasive and burdensome treatments. 


Principal Investigator



Overlake Medical Center
1035 116th Ave NE 
Bellevue, WA 98004

Phone: (425) 688-5000